9 Meters Biopharma Price to Book Ratio

The latest P/B ratio for NMTR is -0.07. That is below the Technology sector average of 18.01. Investors often review this figure alongside 9 Meters Biopharma's historical trend and sector peers before judging valuation or financial health.

Against Technology companies, NMTR currently prints -0.07 for P/B ratio, while the sector average sits near 18.01. That is roughly 100.4% below the sector mean. Large gaps often invite a closer look at 9 Meters Biopharma's growth, margins, and balance sheet.

A P/B ratio of -0.07 for 9 Meters Biopharma is not 'good' or 'bad' on its own. Compare it with the peer average (18.01) and with NMTR's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting NMTR's P/B ratio (-0.07), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 9 Meters Biopharma's P/B ratio against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.